IMMUNOGLOBULIN A NEPHROPATHY (IGAN) PATIENT BASELINE CHARACTERISTICS IN ASIAN VERSUS NON-ASIAN REGIONS IN THE SPARSENTAN PROTECT STUDY
Back
Abstract Number
WCN23-1181
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
IMMUNOGLOBULIN A NEPHROPATHY (IGAN) PATIENT BASELINE CHARACTERISTICS IN ASIAN VERSUS NON-ASIAN REGIONS IN THE SPARSENTAN PROTECT STUDY
Co-authors
Wong, M.G.(1)*;Barratt, J.(2);Komers, R.(3);Mercer, A.(4);Rovin, B.(5);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)University Of Sydney, Renal Medicine- Concord Repatriate General Hospital, Concord, Australia;(2)University Of Leicester General Hospital, Department Of Cardiovascular Sciences, Leicester, United Kingdom;(3)Travere Therapeutics- Inc., Nephrology, San Diego, United States;(4)Jamco Pharma Consulting, Nephrology, Stockholm, Sweden;(5)Ohio State University Wexner Medical Center, Division Of Nephrology, Columbus, United States;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/c47f476f50307e3de18b0f7cd518b3b5.pdf
Audio File
if any